miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients
Author:
Funder
Science and Technology Commission of Shanghai Municipality
Publisher
Elsevier BV
Subject
Molecular Biology,Biochemistry,Biophysics
Reference35 articles.
1. Hepatocellular carcinoma;Forner;Lancet,2018
2. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Primers,2016
3. Letter to the editor: hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: a comment for moving forward;Mo;Hepatology,2019
4. PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients;Han;J. Hepatol.,2015
5. Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance;Singh;Int. J. Canc.,2015
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy;Cancer Letters;2023-06
2. MiRNA-93: a novel signature in human disorders and drug resistance;Cell Communication and Signaling;2023-04-19
3. Non-coding RNAs and macrophage interaction in tumor progression;Critical Reviews in Oncology/Hematology;2022-05
4. Useful genes for predicting the efficacy of transarterial chemoembolization in hepatocellular carcinoma;Journal of Cancer Research and Therapeutics;2022
5. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems;Seminars in Liver Disease;2021-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3